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IT was observed in earlier experiments of the present authors that the intro-
duction ofheparin components into the organism (i.e. glucuronic acid andglucos-
amine) promoted, while the chemical binding ofheparin inhibited, the growth of
experimental tumours. Combined treatment with toluidine blue, thionine or
protamine sulphate, i.e. with heparin-binding substances, resulted in a marked
inhibition ofmalignant growths in test animals (Csaba, Horva'th and Acs, 1960;
Csaba, Acs, Horva'th and Kapa, 1960). It has long been known that there exists
a certain correlation between tumours andpolysaccharides (Almquist andLansing,
1957 ; Asboe-Hansen, 1954 ; Koenig, 1955 ; Rottimer, Levy and Conte, 1958 ;
Weimer, Quinn, Redlich-Moshin andNishihara, 1957; Winsler and Smyth, 1948);
certain authors actually regard heparin as a growth-inhibitor (Bala'zs and Holm-
gren, 1949; Koenig, 1955)
. Though opinions are fairly contradictory, authors
are in agreement regarding the observation that a multiplication of mast cells
invariably occurs in the vicinity of tumours, and that both the appearance and
multiplication of these heparin-containi'ng cells are associated with progressive
tumorous growth (Fromme, 1906 ; Higuchi, 1930 ; Quensel, 1933 ; Staemmler,
1921 ; Weill, 1919).
Our earlierinvestigations into theorigin ofmast cells and theircapacity to take
up heparin convinced us that the thymus played aprominent part in the produc-
tion of mast cells. They arise in this organ from reticular cells as also from large
and medium-sized thymocytes. A reaction of the thymic tissue can be observed
in tumorousorganisms or those in a state of tissueproliferation : cysts containing
a substance sensitive to Schiff's periodic reaction (PAS-positive) are formed in
the thymus, and this process is associated with the appearance of PAS-positive
thymocytes, the major part of which changes into mast cells (Csaba and Ka a, p
1960 ; Csaba, T&6, Acs and Kiss, 1960 ; Csaba, T6r6 and Kapa, 1960). These
investigations seemed to prove that the presence of tumours meant aprovocative
stimulus for thethymus, while the question remained open whether the mast cells
appearing in the vicinity of the tumours were, or were not, of thymic origin.
Such origin appears to be the more questionable as the entire polysaccharide
metabolism of tumorous organisms undergoes modifications which must affect the
mast cells as well.
We tried to approach both theseproblems in our experiments : (a) we studied
mast cell reaction to tumours of different origins (homologous and heterologous
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immune reactions also); (b) we endeavoured to collect data about the origin of
mast cells. Such arrangement of the experiments enabled us to observe tissue
reaction in a state of disturbed tissue correlation (induced tumour), in a state of
tissue immunity (heterologous transplantation) and in cases where disturbed
harmony of the tissues was associated with tissue immunity (homologous trans-
planation).
METHOD
A total of 160 albino mice, obtained from the stock ofthe National Institute of
Pubhc Hygiene, were used as test animals. We divided them into three groups.
Group I consisted of 60 mice: after depilating their skin, we painted it with a
0-5 per cent concentration ofbenzopyrene dissolved in benzene, every other day
du-ring a month and at intervals of 4 or 5 days thereafter. Members ofGroup II
(60 mice) were intracutaneously injected with 0-01 to 0-02 ml. of Ehrlich ascites
tumour, while those of Group III (40 mice) received, likewise intracutaneously,
0-01 to 0-02 ml. of Yoshida tumour suspension.
We removed the first test materials 24 hours after the first treatment and in-
oculation, respectively; test samples were taken hereafter every day during Io
days, and at intervals of 4 to 5 days afterwards. What we isolated was, first, the
painted area of the skin or the site of the intracutaneous inoculation, and, there-
after, the entire tumour which had developed, together with the skin covering it.
We made, moreover, preparations of the membrane obtained from the subcutan-
eous connective tissue situated beneath the painted area of the tumour.
The material was fixed in Carnoy's fluid; we made sections at fourlevels from
each sample, and treated them (as also the membranes) with Giemsa's stain,
toluidine blue or methylgreen pyronin. The PAS reaction, too, was performed.
RESULTS
Disturbance of tissue correlation was represented in our experiments by in-
duced tumours, homologous transplants by Ehrlich's tumour, and heterologous
transplants by Yoshida's tumour.
Time of observations:
1. Induced tumour: samples were taken and examined 19 times, the last at
the appearance ofcornification, or, microscopicaUy, of the first tumour nest.
2. Ehrlich: removal and examination were performed 19 times, the last at
the time when massive ulceration of the skin had begun.
3-,Yoshida: removal and examination 9 times, the last at the time when the
tumour had ceased to be palpable.
Tumours induced by benzopyrene (Fig. I and 2)
Twenty-four hours after first painting: No conspicuous change observable
either in the epithelium or the connective tissue.
Forty-eight hours: Considerably increased number of mast cells, mostly
appearing in the connective tissue, at some distance from the epithelium, between
the sebaceous glands or the hair follicles. They are intensively granulated, of
various shapes, and only a few of them show the regular form of mast cells. One
sees mostly ceRs with processes which resemble either fibroblasts or macrophages.329 GENESIS AND FUNCTION OF MAST CELLS
Seven days: Number of mast cells as after 48 hours. Advancing cornification
ofepithelium; pycnosisandkaryorrhexisobservable inthecells. Thephenomenon
becomes pronounced on the 5th day when the epithelium forms cones in the cutis
and also the epithelium of the hair foRicles begins to proliferate. These follicles
show dilatation so that the hairs they contain appear as pearls; epithelial de-
generation and much nuclear fragmentation can be seen. Metachromatic matter
accumulates around the swollen hair follicles, and it is not possible to determine
at this time whether this substance derives from the broken-up mast cells.
Ten days : Further progress of cornification, with the appearance of vast
numbers of mast cells. Many irritomotile figures among the other connective
tissue cells. Mast cells provided with numerous processes, their granulation un-
even. They are hyperchromatic, but number of disintegrated cells is still very
low.
Fifteen days: Further increase in the number of mast cells. These, too, are
provided with processes and stain metachromatically. They are situated in the
cutis, some of them near the epithelium. Many of the mast cells are broken up
and their granules scattered in the connective tissue.
Twenty-three days: The epithelial structure appears to be basally loosened
at certain points where a direct contact between mast cells and epithelial cells is
established.
Samples taken on the 28th, 33rd, 39th, 44th, 50th and 57th days show a high
degree of cornification ; one can well observe the penetration ofepithelial cones
towards thedeeperlayersand, as from the 40thday, thedisintegration ofepithelial
structure. Contact between mast cells and epithelial cells is so close by the 33rd
day that occasional mast cells appear among the epithelial cells both in the epi-
thelial cones and the hair foflicles. They show the typical form of mast cells and
are so numerous in the immediate vicinity of the epithelium that the epithelial
cells are fully covered up at certain points. Cells, provided with nuclei character-
istic of epithelial cells, can be seen in close contact with the epithelial cones, as
from the 40th day. Vast numbers of mast cells are degenerating in certain areas.
Hardlyanything but mast cells are visible in certainparts ofthe connective tissue,
especially in the neighbourhood of the epithelium.
Sixty-two days: Associated with one of the epithelial cones, the appearance
oftumorous substance can be observed. Mast cell reaction is very intensive around
the tumour cells.
PAS reaction revealed no pronounced increase in the amount ofneutral muco-
polysaccharides. While noplasmacytes were observable inthepreparations stained
withmethylgreenpyronin, they showed the presence of numerous mast cells which
were vividly metachromatic upon being stained with methylgreen.
Only a moderate number ofregularly shaped mast cells was observable in the
membrane preparations on the 2nd day. They became, however, exceedingly
numerous after 10 days, and it was at this time that their disintegration began.
The cells contained many vacuoles, and their hypergranulation increased as time
went on. There were numerous disintegrated figures also among the mast cells
situated beside the capillaries. Disintegration was so rapid that only occasional
unimpaired mast cells had remained by the 39th day. The entire subcutaneous
connective tissue had filled up with granules in the area of painting. Even the
remaining few more or less unimpaired mast cells were stuffed with granules
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Ehrlich's tumour-homologous transplantation (Fig. 3 to 12)
At 24 hours after transplantation : The implanted cells, forming densely
packed bundles, are situated in the cutis. Detritus is observable in certain areas.
That the cells are alive is shown by the intensive pyroninophilia ofthe cytoplasm.
Forty-eight hours : The central portion of the implant becomes necrotic, with
the marginal part remaining alive. A few mast cells observable towards the epi-
thelium, among the sebaceous glands. Tumour cells begin to spread between the
connective tissue cells.
Four days : The necrotic part is almost completely absorbed in some, and
still present in other, cases. Migration of the cells is pronounced : the emigrant
cells form epithelial islets in which many atypical mitoses can be seen. Mast cell
reaction becomes stronger.
Five days: Tumorous growth is more advanced. It is on the .5th day that a
contact between mast cells and tumour cells is established on that aspect of the
tumour which is directed towards the epithelium. Tumour cells approximate,
sometimes even reach, the epithelium.
Six days : Mast cell reaction becomes niore and more pronounced : the visual
field of a 10 x-objective shows 60 to 70 mast cells in the connective tissue. They
have either a regular shape or show a number of processes. Even cells containing
metachromatic granules are sometimes observable between the connective tissue
cells, always iiear the epithelium.
Seven days : Further increase in the number of mast cells. They begin to
disintegrate in certaiii areas. Recurrence of central necrosis as the tumour is
spreading. Mast cells already visible between tumour cells.
EXPLANATION OF PLATES
Fw.. L-Skin treated with betizopyrene ; preparation of inembi-aiie froiii subeutaneous con-
nective tissue on 2nd day. Toluidine blue. x 100.
Fia. 2.-Skin treated with benzopyrene ; preparation of inembrane froin subcutaneous coii-
nective tissue on 12th day. Toluidine blue. x 200.
Fio. 3.-Intracutaneously implanted Ehrlich tumour. 6th day. Appearance of mast cells,
beneath epithelium, far from tumour. Two mast cells of different tylies visible in enframed
area. Toluidine blue. x 100.
Fi(,,,. 4.-Enlarged detail ofFig. 3. The letter E indicates eell of the epithelia], the letter C that,
of the connective-tissue type. Toluidine blue. x 400.
Fi(,,,. 5.-Intracutaneously implanted Ehrlich tumour ; 6th day. Nurnerous mast cells adjacent
to epithelium. Giemsa stain. x 100.
Fi(-.,. 6.-Intracutaneously implanted Ehrlich tumour ; 12th day. Mast cells detaching froiii
epithelium. Toluidine blue. x 400.
Fio. 7.-Intractuaneously implanted Ehrlich tumour; l2th day. Mast cells detaeliing from
epithelium (indicated by M). Giemsa stain. x 400.
Fi(,,,. 8.-Intracutaneously implanted Ehrlich tumour; 12th day. Mast cells detaching from
epithelium (indicated by M). Giemsa stain. x 400.
Fic.. 9.-Intracutaneously implanted Ehrlich tumour; 18th day. Vast nuii-ibers of mast cells
in immediate contact with epithelial elements. Toluidine blue. x 100.
Fic,,. IO.-Intracutaneously implanted Ehrlich tumour; 18th day. Mast cells in close contact
with epithelium. Toluidine blue. x 100.
Fi(;. II.-Intracutaneously implanted Ehrlich tumour; 21st day. Epithelium approached
and destroyed by tumour. Mast cells of epithelial character (indicated by M). Toluidine
blue. x 200.
FiG. 12.-Subcutaneous connective tissue 38 days after implantation of Ehrlich tumour.
Numerous disintegrating or disintegrated mast cells. Membrane preparation. Toluidine
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Eight to twelve days: Further growth of tumour and progress of mast cell
multiplication.
Twelve days : Further disintegration of mast cells, vast numbers ofwhich are
to be found in the tumour and around the epithelial cells. Certain ofthe latter fill
up with metachromatic granules and become detached. Whole picture dominated
by mast cell transformation. Tumour reaches epithelium at some points, giving rise to ulceration.
Eighteen days : Further increase in the number of mast cells. Those situated
near the epithelium are paler, less granular and show weak azure metachromasia ;
those lying near the tumour are hypergranulated, show a darker colour and tend
to disintegrate.
Twenty-one days: Number of mast cells less than before, since tumour has
reached the epithelium almost everywhere, but transformation ofepithelial cells
into mast cells still observable. Cells detach themselves from the Mal-pighianlayer, and it can be well seen that the nuclear structure ofintra-epitheliai m,-"ast cells is
the same as that of cells situated in the germinative layer.
Twenty-four to thirty-eight days : Tumour attains the size of a hazelnut
general ulceration ; occurrence of mast cells at points where contact between
epithelium and tumour not yet established, but most of them situated in the
tumorous substance even at such points.
Great numbers of strongly garnulated mast cefls, arranged in groups, can be
seen to appear in the membrane preparations, i.e. in the subcutaneous layer, 24
hours after transplantation. Their further growth and proliferation take prac- tically the same course as that described in connection with induced tumours.
Staining with methylgreen pyronin revealed no plasmacytes either in the mem-
branes or the sections.
Y08hida'-s tumour-heterolQgOU8 tran8plantation
Much detritus and many degenerated cells can be seen as early as 24 hours
after the inoculation, and practically all cells become necrotic after 48 hours.
Both connective tissue reaction and plasmacyte reaction begin on the 4th and
become very pronounced on the 7th day. The tumour ceases to be pal able at
the site of inoculation on the 8th day, its place being taken everywhere by con-
nective tissue.
Plasmacyte reaction begins on the 4th to 5th day, and takes its full course
until about the 8th day. Mast cell reaction appears on the 7th day and is still in
progress on the 8th and 9th day. Mast cells resembleeithermedium sized thymo-
cytes or macrophages.
Some of the plasma cells are true to form, but there occur also cens which, though plasmacyte-like, have no typical nuclei, while their cytoplasm is strongly pyroninophilic. They occur mostly in groups with only a few being scattered.
The greatest number of mast cells are to be found between the proliferating connective tissue cells.
DISCUSSION
We observed the most pronounced mast cell reaction in cases of induced
tumour; it was almogt as intensive in c'ases of homologous transplantation (Ehrlidh's tumour), while a decidedly weak reaction followed heterologous trans-.1
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plantations (Yoshida's tumour). On the other hand, plasma cell reaction occurred
only in cases ofheterotransplantation.
What are we justified to conclude from these observations ?
lt emerged from our earlier experiments that mast cell reaction was the organ-
ism's response to disturbances affecting the correlation oftissues, e.g. to tumorous
growths (Csaba, T6r6 and Kiss, 1959). A reaction ofthis kind was observed in the
thymus. These earlier observations seein to be substantiated by the results of
our present experiments derangement of the harmonv between tissues, i.e.
tissue proliferation, occasioned the appearance or formation of an exorbitantly
large number of mast cells, aphenomenon quite in harmony with the observations
of Elirlich (1877), Westphal (1880), Higuchi (19.30), Asboe-Hansen (1954), Asboe-
Hansen, Levi and Wegelius (1957) and Lengyel and ATe'rtes (1953) who reported
on the appearance of numerous mast cell-s in the vicinitv of tumours. However,
the experiments of these authors failed to clear up the cause of this phenomenon.
Our present experiments seem to justify us in suggesting that it is not the simple
presence of tumour but the process of proliferation which mobilizes mast cells :
we have seen that Yoshida's tumour, which belongs to the non-proliferative type,
provoked but a very mild mast cell reaction, and even that at a time when the
absorption of the growth, the process of repair, had already begun, i.e. coinci-
dentally with connective tissue proliferation. It shows that mast cell reaction was
associated also in this case with tissue motility rather than with the presence of
tumour, while the influence of foreign proteins gave rise to the appearance of
plasma cells, so that the picture was dominated by the representatives of tissue
immunity.
It has been noted that onlv a part of the plasma cells showed the
" classic
forni of plasmacytes ; yet, although the spoke-like arrangement of the nuclear
structure was not observable in others, other morphological features and their
strongly pyroninophilic cytoplasm revealed also these forms as plasmacvtes.
Mast cells showed still wider variations of form. A
" regular
" mast cell has, as is
known, a round or oval shape and contains in its cytoplasm granules which react
with metachromasia to toluidine blue or azure ; its nucleus, stainiiig bright with
these dyes, is situated in the centre or slightly eccentrically. Although there
occurred a few which showed this
" classic
" forin, most of the mast cells in the
neighbourhood oftumoursdisplavedsignificantly different morphological features.
The greatest number-especially those situated in the loose connective tissue-
liad processes and contained atypical nuclei ; the granularity of their cytoplasm
was not always pronounced: instead ofgranules, a homogeneous metachromatic
substance was observable in certain instances, while-in other cases-the mast
cells rather resembled fibroblasts, macrophages or epithelial cells.
A survey of literature on the origin of mast cells reveals the fact that mast
cells may arise from a great number of other cell tvpes. While macrophages are
transformed into mast cells according to 17elicanand Velican (1959) it is suggested
by Burkl (I952) that mast cells arise as a result ofthe storage ofheparinby histio-
cytes ; again, other authors derive them from fibroblasts, while our investigations
seem to show that most ofthe mast cellsoriginate in thethymus from the reticular
cells of the epithelium or the large and medium-sized thyniocytes. If one accepts
all these suggestions (and our present experiments make us inclined to do so) we
have to regard as mast cells all cells containing metachromatic granules in the
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think this definition covers all afore-mentioned forms. We do not want to suggest
that all mast cells are ofequal value, and this the less so as a notion of this kind
takes but a single component of the mast cell into consideration, namely heparin,
although it contains also histamine, serotonin and a number of other substances.
It appears from our present experiments that the first mast cells appearing
around tumours arise from the connective tissue and subsequent ones from the
epithelium, while those present in the subcutaneous connective tissue are rather
suggestive ofthe
" classic
" form ofmast cells, i.e. ofthymocyticorigin. Mast cells
of epithelial origin require, however, further discussion. They appear in an ad-
vanced phase of tumorous proliferation in the case of both Ehrlich's tumour and
in that ofprotracted cancerogenic painting. Yet, also those mast cells which we
regard as originating from connective tissue cells emerge close to the epithelium,
and appear in larger numbers near the epithelium even when the tumour is still
at a distance from it. That this is so has been confirmed in the course of our
earlier experiments conducted in connection with the thymus. It was found that
induction by the epithelium was required for the emergence of mast cells and that
the epithelial cells themselves changed into mast cells at a certain stage. That
the impulse given by the epithelium is of high significance is well borne out by literatureaccording to which mast cell reaction is much weaker in cases of sarcoma
than in those of carcinoma, so that, apart from the process of proliferation, the
epithelial'or non-epithelial character of tumours, t'oo, influences the intensity of
mast cell reaction.
The fact that, with advancing proliferation, part of the epithelium itself
changes into mast cells, seems to indicate the defensive character of the reaction,
as has beenrecognizedby a number ofearlier authors. It was found, for instance,
by Cramer andSimpson (I944) that mast cell reaction was more marked in animals
that showed stronger resistance to thegrowth ofinduced tumours. Koenig (1955)
claims that mitosis of tumour cells comes to a standstill ifgreat numbers of mast
cells are present. That the presence of mast cells inhibits tumorous growth is
attributed b these authors to heparin which is liberated by disintegratin mast y 1_1 cells : this substance is know-n as an antagonist ofhyaluronidase and an inhibitor
ofmitoses (Glick andSylve'n, 1951 ; Greenstein, 1954 Holmgren andWohlfahrt,
1949 ; Bala'zs and Holmgren, 1949 ; Harding, 1949 Fischer, 1936 ; Heilbrunn,
1956 ; Heilbrunn and Wilson, 1949). Our earlier investigations do not support this view: heparin (or rather, its components) were found to promote malignant growth, and tumours-far from being antagonized by heparin-seemed to be in
need ofthis agent for their development. This is substantiated by the findings of
Panizzari and Vegeto (1958), as also by those of Ozzello, Lasfargues and Murray (1960). In thelight of our own observations and those of the last-named authors,
it would appear that mast cells antagonize tumorous growth by taking up, and
so depriving tumour cells of, heparin : mast cells appear as a kind of competitor oftumour cells in their quest ofheparin, so that the mechanism ofinhibition would
seem to operate not through a release of heparin but its cellullar neutralization.
The defence oftheorganismwould, theref6re, consist inheparinbeing taken up by the cells of the connective tissue and the epithelium, their consequent trans-
formation into mast cells, and not the other way round. That this hv-pothesis is
correct seems to be corroboratedby the observation that mast cells in16 vicinity of the epithelium contain less heparin than those near the tumour (Sylve'n, 1945,
came to the same conclusion) which shows that cells take up heparin
" en route
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arrive at the tumour in the form of mature mast cells and release their heparin
content in its vicinity. Mast ceRs, therefore, do not produce heparin but absorb
and neutralize this substance.
As regards disintegration of mast cells, this occurs frequently both near the
tumour and in the more distant subcutis withadvancingproliferation. This would
mean'as hasalready beenpointed outby us, that the decomposition of mast cells
is not due to mechanical traumatization but to a factor which becomes operative
in theorganism with thespread oftumorousgrowth. It ispossible that the defence
mechanism oftheorganismis overthrownbythe tumourwhich utilizes theheparin
of mast cells in such cases for its own growth, but it is likewi'se possible that the
tumour is unable to utilize it in that complex form in which heparin is contained
in mast cells. Nor is itimpossible that, at thistime, thehyaluronidaseantagonism
ofwhole heparin is already stronger than the tumourpromoting effect ofthe indi-
vidual heparin components. No doubt, there seems to exist a certain contra-
diction between defence by means of mast cells and the fact that these cells so-to-
say
" dish up
" their heparin content to the tumour; the problem needs filrther
investigation before we can expect to solve it.
To sum up: mast cell reaction seems to be a characteristic concomitant of
states in which tissue correlation is disarranged, since it occurs also in pregnancy,
wound healing and processes of regeneration, while plasmacyte reaction appears
as the local manifestation of tissue immunity. It is quite possible that both reac--
tions are but different cytological manifestations of the organism's defence. Our
experiments failed to clear up the question why only mast cell reaction (i.e. one
characteristic of states of correlation disturbances) appeared in cases of homo-
logous tumour transplantation, although the presence of homologous protein
would have justified the appearance ofplasma cell reaction. It seems that, when
the transplant (namely Yoshida's tumour) was weakly proliferative but strongly
antigenic, antigenicityprevailed and gave rise toplasma cellreaction, while, when
the transplant (namely Ehrlich's tumour) was weakly antigenic but strongly
proliferative, proliferation prevailed and gave rise to mast cell reaction.
SUMMARY
Experiments are described, made with a view to studying the origin and
function of mast ceUs in the vicinity of induced (benzopyrene), homologous
(Ehrlich) and heterologous (Yoshida) tumours. It was found that the organism
responded with mast ceR reaction to disturbances of tissue correlation, and de-
velopedplasma cellreactionin states oftissueimmunity. It is suggested that mast
cells, which may have various origins, inhibit tumorous growth by neutralizing
thepolysaccharides, necessary for adevelopment oftumours, in the course oftheir
genesis, i.e. during the process in which other celltypes are transf6rmed into mast
cells. Varioustheoriesregardingtheoriginofmast cells andtheir tumourinhibiting
function are discussed.
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